HCAP Partners recently announced a significant investment in Real Diagnostics, a clinical laboratory renowned for its commitment to rapid and accurate testing. This strategic partnership is designed to support Real Diagnostics’ capabilities across several crucial areas, including the diagnosis of urinary tract infections (UTIs), comprehensive toxicology screenings, testing for various respiratory conditions, and a range of women’s health diagnostics.
The investment plays a vital role in supporting Salt Creek Capital’s acquisition of Real Diagnostics, signaling a shared vision for expanding access to high-quality diagnostic services for a broader population. The details of this investment have not been publicly disclosed.
Real Diagnostics currently serves physician offices, specialty clinics, and skilled nursing facilities across an impressive 17 states. What truly sets the company apart in the diagnostic landscape is its unwavering dedication to efficiency and accuracy. Patients and healthcare providers benefit greatly from Real Diagnostics’ commitment to delivering test results within 24 hours. Furthermore, physicians have direct access to knowledgeable lab staff, fostering clear communication and ensuring that test results are interpreted with precision. The company also leverages its own proprietary technology, which continuously works to enhance the accuracy of its diagnostic processes.
A significant development accompanying this investment is the appointment of Cary Breese as the incoming CEO of Real Diagnostics. Mr. Breese brings a wealth of experience, spanning over two decades, in leadership roles within the healthcare and technology sectors. His impressive career includes co-founding NowRx, where he successfully scaled revenues to $35 million. Before that, he skillfully guided an InsurTech venture to a successful exit, demonstrating his expertise in strategic growth and market leadership. His extensive background is expected to drive Real Diagnostics to new heights of innovation and operational excellence.
Beyond financial support, HCAP’s investment is also geared towards helping Real Diagnostics implement the Gainful Jobs Approach. This is HCAP’s unique and proprietary framework specifically designed to elevate job quality standards throughout a company’s workforce. Real Diagnostics has already established a strong foundation of job quality within its organization. With HCAP’s collaboration, the company will further strengthen its workplace policies, create expanded career pathways for its employees, and enhance overall opportunities as Real Diagnostics continues its journey of growth and expansion. This commitment to employee well-being and professional development underscores the holistic approach taken by both HCAP and Real Diagnostics.
The deal was led by Stefan Okhuysen, Ben Consoli, and Bekhruz Nuriddinov of HCAP Partners.
KEY QUOTES:
“RealDx stands out with technology that delivers greater accuracy and faster results for providers. Its focus on operational excellence and commitment to workforce quality aligns well with our approach to supporting healthcare companies that create both strong business outcomes and meaningful impact.”
Stefan Okhuysen, Partner at HCAP Partners
“The company has built a strong foundation of innovation and trusted partnerships with providers. With the support of Salt Creek Capital and HCAP Partners, we are well-positioned to expand our reach and continue delivering timely, accurate diagnostics that improve patient care.”
Cary Breese
“RealDx is entering its next phase with a strong leadership team and clear opportunities to expand its geographic footprint and payor relationships. We are pleased to partner with Cary, HCAP, and the management team to scale the business and build on its reputation as a trusted provider of advanced diagnostic services.”
Dan Mytels, Managing Partner of Salt Creek Capital
